Ketamine IV for the prevention of depression in the elderly: new data

Published Date: 13 Mar 2023

Intravenous (IV) ketamine is effective in adults resistant to depression. The response was similar to that seen in younger patients, two new studies show.

Read Full News

Latest News

UK Moves to Criminalise Gender and Sexuality Conversion Therapies

Britain on Thursday set out plans to criminalise ⁠abusive and harmful therapies intended to change a person's sexual orientation ⁠or gender identity.

Indoxyl Sulphate Levels Tied to Cognitive Impairment in CKD

Among key uraemic toxins derived from tryptophan, higher indoxyl sulphate levels are independently associated with a greater likelihood of cognitive impairment in patients with chronic kidney disease.

Can Migraine Treatment Improve Cognitive Function?

Preventive treatment with anti-CGRP monoclonal antibodies or botulinum toxin not only reduces a headache burden but also improves executive cognitive function in patients with migraine.

Case Builds for Using Ultrasound in the Management of HS

Research has documented the discordance between severity determined through the clinical exam and severity as seen on ultrasound.

Patient’s Complaint Can Put Hospitalists on the Spot to Act

As a leader, those complaints may be made to you. How you handle them tells the patient a lot.

Maternal Mortality in Canada: Beyond the Delivery Room

Improving maternal mortality in Canada requires the prioritization of women’s health, especially during the reproductive years, experts say.

Todays Updates

Time to Rethink Maintenance Pemetrexed in NSCLC?

For patients with advanced non-small cell lung cancer (NSCLC), adding pemetrexed to maintenance pembrolizumab may only increase toxicity, not survival.

Todays Updates

Time to Rethink Maintenance Pemetrexed in NSCLC?

For patients with advanced non-small cell lung cancer (NSCLC), adding pemetrexed to maintenance pembrolizumab may only increase toxicity, not survival.

Latest News

Britain on Thursday set out plans to criminalise ⁠abusive and harmful therapies intended to change a person's sexual orientation ⁠or gender identity.

Among key uraemic toxins derived from tryptophan, higher indoxyl sulphate levels are independently associated with a greater likelihood of cognitive impairment in patients with chronic kidney disease.

Preventive treatment with anti-CGRP monoclonal antibodies or botulinum toxin not only reduces a headache burden but also improves executive cognitive function in patients with migraine.

Research has documented the discordance between severity determined through the clinical exam and severity as seen on ultrasound.

As a leader, those complaints may be made to you. How you handle them tells the patient a lot.

Improving maternal mortality in Canada requires the prioritization of women’s health, especially during the reproductive years, experts say.

News All Time

Almost All Of World's Children Exposed to Climate Hazards, UN Agency Says

Almost all of the world's children are exposed to at least one climate hazard, with as many as 1.8 ⁠billion put in danger by droughts and 1.2 billion by extreme heat, the...

AMA Survey: More Doctors Are Embracing AI-Based Tools

More than 80% of respondents say they use AI in their practices, but what that means isn’t always clear.

Functional Neurologic Disorders: Are Signs Being Missed?

Experts encourage earlier recognition of characteristic symptom patterns as prolonged diagnostic delays may worsen recovery and quality of life.

Professional Corner: CPR at World Cup, AMA Leader, More

The American Heart Association brings CPR to the World Cup, American Medical Association names president-elect, and American College of Physicians seeks private equity oversight.

Baby Formula Maker Nara Issues US-wide Recall After FDA, CDC Flag Infant Botulism Cases

Baby formula maker Nara Organics said it is voluntarily recalling all of its infant formula, currently ⁠available in the United States, over potential risk of bacterial...

Suicidality Affects 11% Youth After Sexual Abuse Assessment

Among youth ages 10-17 years evaluated for sexual abuse, more than 11% experienced suicidality within 90 days, with nearly 22% of those attempting suicide.

IM Naloxone Improves Prehospital Opioid Overdose Outcomes

Intramuscular naloxone is linked to better prehospital outcomes, including faster recovery and fewer repeat doses, than intranasal naloxone in patients with suspected opioid overdose, a study finds.

Oxygen Titration Protocol Cuts Severe Hyperoxemia in the ED

An emergency department oxygen titration protocol reduces severe hyperoxemia in mechanically ventilated patients but increases moderate hypoxemia, a study finds.

Feeding Difficulties in Kids Increase Hospital Use and Costs

The presence of feeding difficulties was directly linked to longer hospital stays and higher costs, regardless of other factors.

US Recreational, Unintentional Marijuana Use Surges

Both recreational use and unintentional exposure to marijuana in the US rose significantly from 2015 to 2021, especially in children and adolescents, new survey data show.

ED Overcrowding Linked to Near-Tenfold Rise in Deaths

The RCEM estimates 15,860 deaths were linked to long ED waits in 2025, nearly ten times the 2015 figure.

Europe Faces Growing Synthetic Opioids Risks as Drug Market Evolves, EU Agency Warns

Europe's illicit drug market is undergoing a rapid shift, with synthetic opioids emerging as a concern, although the ⁠region still experiences far fewer fatal overdoses than...

Bipolar: The Warning Signs GPs Can Miss

Bipolar takes an average of 9.5 years to diagnose from first presentation — here's what GPs can do to spot it sooner and intervene before crisis hits.

MRI Signs of Osteitis Pubis Are Common Without Groin Pain

A large population-based study finds that bone marrow oedema and symphyseal cleft signs are common incidental findings on pelvic MRI and do not correlate with self-reported pain.

US FDA to Review AI-based Tool to Predict Drug-related Liver Damage

The U.S. FDA's Center for Drug Evaluation and Research said on Wednesday it has accepted ⁠a letter of intent for an artificial intelligence-based drug development tool...

Bundibugyo Ebola Update: Are New Defenses on the Horizon?

Global health agencies are accelerating vaccine and therapeutic research because the Bundibugyo Ebola outbreak highlights the absence of approved countermeasures.

Recommended News For You

novel technique for early myelodysplastic syndrome relapse detection in blood cancer patients.

The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.

By acquiring T3 Pharma, a leader in bacterial cancer treatment, Boehringer Ingelheim broadens its offering in immunooncology.

Formaldehyde Causes More Cancer Than Any Other Toxic Air Pollutant

What Could This Exploratory 5-Year Survival Data in Adjuvant NSCLC Treatment Mean?

In Relapsed/Refractory Myeloma, Blenrep-Based Regimen Produces PFS Advantage.

The New Perfectionism Problem in Medical Training

Recommended Articles For You

Interpreting Iron Studies: What Your Blood Results Really Mean  

The Benefits and Risks of Thrombolytics: A Comprehensive Guide  

Role of Type I Interferons and KDM1B in Driving Cancer Stemness and Therapeutic Evasion 

Is AI The New Radiologist For Breast MRI? 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

e-Cigarettes and Lung Cancer: Is Harm Reduction Overstated?

2.

FDA Expands Use of T-DXd in Early HER2+ Breast Cancer

3.

Dementia-like protein buildup found in pancreas cells before cancer develops

4.

Un nou sistem de endoscopică imaging are capacitatea de a detecta mai mulți fluorescent tracers.

5.

Inadvertent lung cancer screening results are discussed in a new study.

1.

Unlocking the Power of Cryoprecipitate: A Comprehensive Guide

2.

Understanding Apoplexy: Symptoms, Causes, and Treatment Options 

3.

Protein S-Palmitoylation in Cancer: A Novel Target in Immunotherapy & Treatment

4.

Prognostic Role of PLAU in Pan-Cancer and Neutrophil Infiltration in Bladder Cancer

5.

Beyond Symptoms: The Predictive Promise of Targeted Radionuclide Therapy in Palliative Oncology

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Efficient Management of First line ALK-rearranged NSCLC - Part III

2.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

3.

L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients

4.

INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients

5.

Efficient Management of First line ALK-rearranged NSCLC - Part VIII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot